بدائل البحث:
market decrease » marked decrease (توسيع البحث), largest decrease (توسيع البحث), marked increase (توسيع البحث)
linear decrease » linear increase (توسيع البحث)
step decrease » sizes decrease (توسيع البحث), teer decrease (توسيع البحث)
we decrease » _ decrease (توسيع البحث), a decrease (توسيع البحث), nn decrease (توسيع البحث)
a market » _ market (توسيع البحث), a marker (توسيع البحث)
a linear » _ linear (توسيع البحث)
market decrease » marked decrease (توسيع البحث), largest decrease (توسيع البحث), marked increase (توسيع البحث)
linear decrease » linear increase (توسيع البحث)
step decrease » sizes decrease (توسيع البحث), teer decrease (توسيع البحث)
we decrease » _ decrease (توسيع البحث), a decrease (توسيع البحث), nn decrease (توسيع البحث)
a market » _ market (توسيع البحث), a marker (توسيع البحث)
a linear » _ linear (توسيع البحث)
-
1
-
2
The injectable contraceptives depot medroxyprogesterone acetate and norethisterone enanthate substantially and differentially decrease testosterone and sex hormone binding globulin...
منشور في 2025"…Both contraceptives substantially decreased, from D0 to 25W, the total testosterone [DMPA-IM D0 0.560, 25W 0.423 nmol/L, -24.3% (p < 0.0001); NET-EN D0 0.551, 25W 0.253 nmol/L, -54.1%, (p < 0.0001)], SHBG [DMPA-IM D0 45.0, 25W 32.7 nmol/L, -29.8% (p < 0.0001); NET-EN D0 50.2, 25W 17.6 nmol/L, -65.1% (p < 0.0001)], and calculated free testosterone levels [DMPA-IM D0 6.87, 25W 5.38 pmol/L, -17.2% (p = 0.0371); NET-EN D0 6.00, 25W 3.70, -40.0% (p < 0.0001)]. …"
-
3
Algorithm operation steps.
منشور في 2025"…Experimental results demonstrate that SCI-YOLO11 achieves a 3.2% improvement over baseline models in terms of MAP@0.5 metric; precision and recall rates increase by 2.6% and 3.7%, respectively. Additionally, its parameter count and floating-point operations decrease by 6% and 7.9%, respectively. …"
-
4
Store listing metrics and user acquisition.
منشور في 2025"…</p><p>Methods</p><p>We conducted a pilot quasi‑experimental before‑and‑after study comparing three 6‑month phases—pre‑campaign, campaign, and post‑campaign. …"
-
5
Installation, growth, and retention metrics.
منشور في 2025"…</p><p>Methods</p><p>We conducted a pilot quasi‑experimental before‑and‑after study comparing three 6‑month phases—pre‑campaign, campaign, and post‑campaign. …"
-
6
Implemented activities.
منشور في 2025"…</p><p>Methods</p><p>We conducted a pilot quasi‑experimental before‑and‑after study comparing three 6‑month phases—pre‑campaign, campaign, and post‑campaign. …"
-
7
App user retention trends.
منشور في 2025"…</p><p>Methods</p><p>We conducted a pilot quasi‑experimental before‑and‑after study comparing three 6‑month phases—pre‑campaign, campaign, and post‑campaign. …"
-
8
App user onboarding trends.
منشور في 2025"…</p><p>Methods</p><p>We conducted a pilot quasi‑experimental before‑and‑after study comparing three 6‑month phases—pre‑campaign, campaign, and post‑campaign. …"
-
9
App user base growth trends.
منشور في 2025"…</p><p>Methods</p><p>We conducted a pilot quasi‑experimental before‑and‑after study comparing three 6‑month phases—pre‑campaign, campaign, and post‑campaign. …"
-
10
-
11
-
12
-
13
-
14
-
15
-
16
Uganda 2023 NCD risk factor STEPS survey data.
منشور في 2025"…The risk factor prevalences that increased significantly were: high blood glucose from 1.5% in 2014 to 3.3% in 2023 (p< 0.001); overweight and obesity from 19.3% in 2014 to 24.1% in 2023 (p< 0.001); current alcohol consumption from 28.5% in 2014 to 31.1% in 2023 (p=0.013); and sedentariness from 26.6% in 2014 to 31.9% in 2023 (p< 0.001). The risk factor prevalences that decreased significantly were: inadequate physical activity from 5.0% in 2014 to 3.6% in 2023 (p=0.003), and current smoke tobacco use from 9.6% in 2014, to 8.3% in 2023 (p= 0.046). …"
-
17
Uganda 2014 NCD risk factor STEPS survey data.
منشور في 2025"…The risk factor prevalences that increased significantly were: high blood glucose from 1.5% in 2014 to 3.3% in 2023 (p< 0.001); overweight and obesity from 19.3% in 2014 to 24.1% in 2023 (p< 0.001); current alcohol consumption from 28.5% in 2014 to 31.1% in 2023 (p=0.013); and sedentariness from 26.6% in 2014 to 31.9% in 2023 (p< 0.001). The risk factor prevalences that decreased significantly were: inadequate physical activity from 5.0% in 2014 to 3.6% in 2023 (p=0.003), and current smoke tobacco use from 9.6% in 2014, to 8.3% in 2023 (p= 0.046). …"
-
18
-
19
-
20